For example, patients with pathogenic variants in NFKB2 or IGSF1 or the dual diagnosis of patient 37 (neurofibromatosis and hypophosphatemic rickets) would have been missed by targeted panel sequencing. This evidence concerns the gene NFKB2 and hypophosphatemic rickets.